Revealing the Role of Peg13: A Promising Therapeutic Target for Mitigating Inflammation in Sepsis

Overview

Journal Genet Mol Biol

Specialty Genetics

Date 2024 Jun 10

PMID 38856110

Authors

Dan Wang

Zhiqiang Lin

Meixia Su

Yiqing Zhou

Mengjie Ma

Minghui Li

Affiliations

Soon will be listed here.

Abstract

To investigate the role of Peg13 in modulating the inflammatory response in sepsis, we established Lipopolysaccharide (LPS)-induced 293T cells and mouse models. Peg13 expression was assessed at various time points after infection using RT-qPCR. The levels of high mobility group box 1 (HMGB1) and interleukin-6 (IL-6) were quantified through ELISA. A total of 44 septic patients and 36 healthy participants were recruited to measure Peg13 and HMGB1 levels in the blood. Peg13 demonstrated significant down-regulation in the supernatant of LPS-induced 293T cells and in the blood of LPS-induced mice. Moreover, the levels of proinflammatory cytokines HMGB1 and IL-6 were elevated in both the supernatant of LPS-induced cell models and blood specimens from LPS-induced murine models, and this elevation could be notably reduced by Peg13 suppression. In a clinical context, Peg13 and HMGB1 levels were higher in septic patients compared to healthy subjects. Peg13 exhibited a negative correlation with HMGB1, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) among septic patients. Peg13 mitigates the inflammatory response by reducing the release of proinflammatory cytokines HMGB1 and IL-6 in sepsis, presenting a potential therapeutic target for alleviating inflammation in sepsis treatment.

References

Zampieri F, Machado F, Biondi R, Freitas F, Veiga V, Figueiredo R . Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical Trial. Am J Respir Crit Care Med. 2022; 205(12):1419-1428. DOI: 10.1164/rccm.202111-2484OC. View

Zhang X, Su C, Zhao S, Li J, Yu F . Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway. Bioengineered. 2022; 13(2):2951-2970. PMC: 8973693. DOI: 10.1080/21655979.2021.2024686. View

Wang R, Zhao J, Wei Q, Wang H, Zhao C, Hu C . Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients. J Clin Lab Anal. 2022; 36(8):e24569. PMC: 9396177. DOI: 10.1002/jcla.24569. View

Zanders L, Kny M, Hahn A, Schmidt S, Wundersitz S, Todiras M . Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting. J Cachexia Sarcopenia Muscle. 2021; 13(1):713-727. PMC: 8818599. DOI: 10.1002/jcsm.12867. View

Hensler E, Petros H, Gray C, Chung C, Ayala A, Fallon E . The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers. Front Immunol. 2022; 13:940930. PMC: 9289477. DOI: 10.3389/fimmu.2022.940930. View

Fowler 3rd A, Truwit J, Hite R, Morris P, DeWilde C, Priday A . Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019; 322(13):1261-1270. PMC: 6777268. DOI: 10.1001/jama.2019.11825. View

Shen J, Zhang J, Jiang X, Wang H, Pan G . LncRNA HOX transcript antisense RNA accelerated kidney injury induced by urine-derived sepsis through the miR-22/high mobility group box 1 pathway. Life Sci. 2018; 210:185-191. DOI: 10.1016/j.lfs.2018.08.041. View

Zeng Z, Lan Y, Chen Y, Zuo F, Gong Y, Luo G . LncRNA GAS5 suppresses inflammatory responses by inhibiting HMGB1 release via miR-155-5p/SIRT1 axis in sepsis. Eur J Pharmacol. 2023; 942:175520. DOI: 10.1016/j.ejphar.2023.175520. View

Gao H, Ma H, Gao M, Chen A, Zha S, Yan J . Long non-coding RNA GAS5 aggravates myocardial depression in mice with sepsis via the microRNA-449b/HMGB1 axis and the NF-κB signaling pathway. Biosci Rep. 2021; 41(4). PMC: 8035624. DOI: 10.1042/BSR20201738. View

10.

Liu W, Geng F, Yu L . Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients. J Clin Lab Anal. 2020; 34(6):e23222. PMC: 7307338. DOI: 10.1002/jcla.23222. View

11.

Karimi A, Naeini F, Niazkar H, Tutunchi H, Musazadeh V, Mahmoodpoor A . Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status. Food Funct. 2022; 13(12):6596-6612. DOI: 10.1039/d1fo03746c. View

12.

Peters-Sengers H, Butler J, Uhel F, Schultz M, Bonten M, Cremer O . Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2021; 48(1):92-102. PMC: 8667541. DOI: 10.1007/s00134-021-06574-0. View

13.

Abdul-Aziz M, Sulaiman H, Mat-Nor M, Rai V, Wong K, Hasan M . Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med. 2016; 42(10):1535-1545. DOI: 10.1007/s00134-015-4188-0. View

14.

Li Z, Fu W, Chen X, Wang S, Deng R, Tang X . Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022; 41(1):74. PMC: 8862393. DOI: 10.1186/s13046-022-02291-8. View

15.

Stocker M, van Herk W, El Helou S, Dutta S, Fontana M, Schuerman F . Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017; 390(10097):871-881. DOI: 10.1016/S0140-6736(17)31444-7. View

16.

Ju L, Shi Y, Liu G . Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. PeerJ. 2022; 10:e14506. PMC: 9774008. DOI: 10.7717/peerj.14506. View

17.

Philips C, Maiwall R, Sharma M, Jindal A, Choudhury A, Kumar G . Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int. 2021; 15(4):983-994. DOI: 10.1007/s12072-021-10164-z. View

18.

Sun Y, Niu X, Wang G, Qiao X, Chen L, Zhong M . A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma. Onco Targets Ther. 2020; 13:1519-1531. PMC: 7037065. DOI: 10.2147/OTT.S236158. View

19.

Gu J, Ran X, Deng J, Zhang A, Peng G, Du J . Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation. Int Immunopharmacol. 2022; 108:108730. DOI: 10.1016/j.intimp.2022.108730. View

20.

Carestia A, Mena H, Olexen C, Ortiz Wilczynski J, Negrotto S, Errasti A . Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice. Cell Rep. 2019; 28(4):896-908.e5. DOI: 10.1016/j.celrep.2019.06.062. View